EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant Human Decorin Normalizes the Active Features of Breast Cancer-Associated Fibroblasts

Wafaa A Aljagthmi, Ayodele A Alaiya, Maha Daghestani, Falah H Al-Mohanna iD, Abdelilah Aboussekhra

Cells · 2026

DOI: 10.3390/cells15030311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Wafaa A Aljagthmi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratories, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia. Hauptthemen laut MEDLINE: Decorin, Breast Neoplasms, Cancer-Associated Fibroblasts, Recombinant Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-associated fibroblasts (CAFs), the major constituent of the tumor microenvironment, are considered the most active cells and key contributors to tumor resistance, recurrence, and metastasis. Therefore, we have investigated here the potential normalization of the active features of breast CAFs with decorin (DCN), a small leucine-rich proteoglycan that acts as an oncogene suppressor. We have first shown that rhDCN modulates the expression of a plethora of proteins involved in different signaling pathways, including STAT3/NF-κB and ERK. Consequently, rhDCN repressed the important active CAF biomarkers α-SMA, IL-6, and SDF-1 through inhibition of the STAT3/AUF-1 pathway, in cells grown as 2D and 3D cultures. Furthermore, rhDCN had a strong downregulation effect on FAP-α, a key biomarker of active CAFs, and suppressed their proliferative and invasive capacities through upregulation of p16 and p21, and downregulation of MMP-2 and MMP-9. Furthermore, rhDCN suppressed the paracrine effects of active CAFs in promoting epithelial-to-mesenchymal transition (EMT) and cancer stem cells in breast cancer cells, both in vitro and in orthotopic tumor xenografts. Importantly, rhDCN-related normalization of active CAFs features was persistent through cellular passaging, and was not accompanied by cytotoxicity. Together, these findings have revealed rhDCN as a promising anti-breast cancer therapeutic cytokine through suppression of the non-cell-autonomous cancer-promoting effects of active CAFs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DecorinBreast NeoplasmsCancer-Associated FibroblastsRecombinant ProteinsHumansFemaleAnimalsEpithelial-Mesenchymal TransitionCell Line, TumorCell ProliferationSignal TransductionFibroblast Activation Protein AlphaTumor MicroenvironmentNeoplastic Stem CellsMiceSTAT3 Transcription Factor

Stichwörter der Autor:innen

CAFsDCNbreast cancercancer stem cells

Substanzen

DecorinRecombinant ProteinsFibroblast Activation Protein AlphaDCN protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Research Laboratories, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
  • Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.

ORCID-Profile: Falah H Al-Mohanna

Zitieren

APA

Aljagthmi, W. A., Alaiya, A. A., Daghestani, M., Al-Mohanna, F. H., & Aboussekhra, A. (2026). Recombinant Human Decorin Normalizes the Active Features of Breast Cancer-Associated Fibroblasts. Cells. https://doi.org/10.3390/cells15030311

Vancouver

Aljagthmi WA, Alaiya AA, Daghestani M, Al-Mohanna FH, Aboussekhra A. Recombinant Human Decorin Normalizes the Active Features of Breast Cancer-Associated Fibroblasts. Cells. 2026. doi:10.3390/cells15030311

BibTeX
@article{Aljagthmi2026,
  author = {Aljagthmi, Wafaa A and Alaiya, Ayodele A and Daghestani, Maha and Al-Mohanna, Falah H and Aboussekhra, Abdelilah},
  title = {Recombinant Human Decorin Normalizes the Active Features of Breast Cancer-Associated Fibroblasts},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15030311}
}
Kostenlos starten →